Amgen Soars After CEO Gives Update on Experimental Obesity Drug

Amgen Inc.’s shares soared in late trading after its chief executive officer said he was “very encouraged” by early results from a study of the company’s experimental obesity drug, MariTide. • None Saudi Arabia Steps Up Arrests Of Those Attacking Israel Online • None Turkey Confirms All Trade Halt…#amgenincs #maritide #gaza #reshapemiddleeast #amgen #robertbradway #thousandoaks #elilillyco #novonordiskas #michaelshah
Source: Reuters: Health - Category: Consumer Health News Source Type: news